MARKET

RVMDW

RVMDW

Revolution
NASDAQ
9.50
-0.03
-0.31%
Closed 15:59 07/24 EDT
OPEN
9.83
PREV CLOSE
9.53
HIGH
9.83
LOW
9.32
VOLUME
21.07K
TURNOVER
--
52 WEEK HIGH
10.12
52 WEEK LOW
0.1600
MARKET CAP
--
P/E (TTM)
-1.3393
1D
5D
1M
3M
1Y
5Y
1D
Revolution Medicines (RVMD) Is Up 5.3% After FDA Priority Review For Pancreatic Cancer Drug Approval Bid
Simply Wall St · 1d ago
FDA Accepts RVMD's Filing for Daraxonrasib in Pancreatic Cancer
NASDAQ · 1d ago
Revolution Medicines Is Maintained at Outperform by Wedbush
Dow Jones · 1d ago
Wedbush Maintains Outperform on Revolution Medicines, Raises Price Target to $192.1
Benzinga · 1d ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: McKesson (MCK), Revolution Medicines (RVMD) and Molina Healthcare (MOH)
TipRanks · 1d ago
Wedbush Sticks to Their Buy Rating for Revolution Medicines (RVMD)
TipRanks · 1d ago
Revolution Medicines price target raised to $192.10 from $181 at Wedbush
TipRanks · 1d ago
REVOLUTION MEDICINES INC <RVMD.O>: WEDBUSH RAISES TARGET PRICE TO $192.1 FROM $181
Reuters · 2d ago
More
About RVMDW
Revolution Medicines, Inc. is a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers. The Company’s research and development pipeline comprises RAS(ON) inhibitors that bind directly to RAS variants, which it refers to as RAS(ON) Inhibitors, and RAS companion inhibitors that target key nodes in the RAS pathway or associated pathways, which it refers to as RAS Companion Inhibitors. Its RAS(ON) Inhibitors are designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or in combination with RAS Companion Inhibitors or other therapeutic agents. Its RAS Companion Inhibitors are designed primarily for combination treatment strategies centered on its RAS(ON) Inhibitors. The Company’s RAS(ON) Inhibitors RMC-6236 RMC-6291 and RMC-9805 are in clinical development. RMC-6236, its RASMULTI(ON) inhibitor, is designed as a potent, oral, RAS-selective tri-complex inhibitor of multiple RAS(ON) variants, including cancer drivers.

Webull offers Revolution Medicines Inc stock information, including NASDAQ: RVMDW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RVMDW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RVMDW stock methods without spending real money on the virtual paper trading platform.